What Is a Preclinical CRO?

A Preclinical Contract Research Organization (CRO) is a company that conducts research and testing on pharmaceuticals and medical devices before they enter clinical trials.

How big is the Preclinical CRO Market?

The global Preclinical CRO Market size was estimated at USD 5.2 billion in 2022 and is expected to reach USD 10.5 billion in 2032.

What is the Preclinical CRO Market growth?

The global Preclinical CRO Market is expected to grow at a compound annual growth rate of 7.5 %. From 2023 To 2032

Who are the key companies/players in the Preclinical CRO Market?

Some of the key players in the Preclinical CRO Markets are PAREXEL International Corporation, Laboratory Corporation of America Holdings, Medpace, Inc., Envigo Corporation, Charles River Labs, PRA Health Science, Inc., PPD Inc., Covance Inc., Other Key Players.

Why Are Preclinical CROs Important?

Preclinical CROs play a crucial role in drug development by assessing the safety and efficacy of potential therapies, helping to bring safer and more effective medicines to market.

Who Uses Preclinical CRO Services?

Pharmaceutical and biotechnology companies, academic institutions, and government agencies often utilize Preclinical CRO services for research and development.

What Types of Studies Do Preclinical CROs Conduct?

These organizations perform a wide range of studies, including toxicity testing, pharmacokinetics, efficacy testing, and formulation development.

How Do Preclinical CROs Impact Drug Development?

They accelerate drug development by providing specialized expertise, equipment, and resources, saving time and costs for pharmaceutical companies.

Global Preclinical CRO Market Size, Share, and Analysis By Services (Toxicology Testing, Safety Pharmacology, Drug Metabolism, Pharmacokinetics, IND Programs, and Others), by Model Type (Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model), By End User (Pharmaceutical and Biopharmaceutical companies, Medical Device manufacturing companies, and Academic Research Organizations, and Other End Users), and Regional Forecast 2023-2032

Published date: Oct 2023
Report ID: 104628
Number of Pages: 226
Format:

- PAREXEL International Corporation
- Laboratory Corporation of America Holdings
- Medpace, Inc.
- Envigo Corporation
- Charles River Labs
- PRA Health Science, Inc.
- PPD Inc.
- Covance Inc.
- Other Key Players.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 104628
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (104)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)